Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

BACKGROUND: Tumour relapse is recognized to be the prime fatal burden in patients affected by head and neck squamous cell carcinoma (HNSCC), but no discrete molecular trait has yet been identified to make reliable early predictions of tumour recurrence. Expression of cell surface proteoglycans (PGs)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Farnedi, Anna, Rossi, Silvia, Bertani, Nicoletta, Gulli, Mariolina, Silini, Enrico Maria, Mucignat, Maria Teresa, Poli, Tito, Sesenna, Enrico, Lanfranco, Davide, Montebugnoli, Lucio, Leonardi, Elisa, Marchetti, Claudio, Cocchi, Renato, Ambrosini-Spaltro, Andrea, Foschini, Maria Pia, Perris, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4429505/
https://ncbi.nlm.nih.gov/pubmed/25935541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1336-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados